Animal Biotechnology Market Synopsis

The global Animal Biotechnology Market size was valued at USD 27.15 Billion in 2022 and is projected to reach USD 63.91 Billion by 2032, growing at a CAGR of 9.98 % from 2024 to 2032.

Animal biotechnology industry or animal biotechnology market therefore refers to any biotechnological uses and processes or technologies with a focus on enhancing animal health, production and well-being. It incorporates genetic technologies, diagnostics, or reproductive biotechnologies for improved stock breeding, vaccine or therapeutic production and generally the quality of animal products. Animal biotechnology enhances better and efficient utilization of animals for livestock production, food sufficiency, and disease control all of which are challenges facing society today. Some drivers that have been determining the market include the global population’s growing appetite for animal derived food products, development in biotechnology and rising awareness in animal welfare and health status.

• There has been a steady market More specifically, the animal biotechnology market has expanded in recent years due to improvements in the genetic engineering industry, reproductive and diagnostic services. It expands to this market that includes genetic modified animals, bio pharmaceutical, and vaccines in attempts to enhance health and production of animals. Animal biotechnology is appreciated together with other biotechnology products as crucial in meeting the escalating global demand for food as people continue to reproduce, using animals to feed human beings through improved productivity, disease resistance and improved health.
• Leading manufacturers and suppliers of animal biotechnology are devoting efforts in research to create new products and techniques in order to overcome difficulties in the livestock industry. This encompasses development biotechnology for crops that can produce foods that are resistant to the various environmental conditions and development of diagnostic equipments that are able to detect diseases in the earliest stage possible. However, one can also see that precision livestock farming, which is the use of technology for monitoring of animal health and Welfare, is a factor that is driving the market growth. With acceptance of GMOs and biopharmaceuticals in different regions the regulatory frameworks are changing, this is also enhancing market growth.
• Among the geographical regions, North America is the largest market for animal biotechnology due to strong research foundation, well developed agricultural base, and increased investment into biotechnology. Though presently the sales seem to be stagnant in Europe and have not risen in North America, the Asia-Pacific region is expected to grow in terms of the market for livestock products, knowledge imparted on animal health, and governmental support. With the increasing focus of consumers on consuming the products of the animal farming method that complies with animal welfare and environment protection, the further developments of this biotechnological market are probable.
• In total, the global market for animal biotechnology is destined for future growth since this sector is vital for solving the problems of the world related to nutrition, improved animal health, and preservation of the environment. Biotechnology has not only improved animal production but also approached problem-solving with answers that conform to consumer preferences for humane, sustainable food production systems. Based on ongoing research improvement in livestock farming and technologically there is great potential for animal biotechnology in the future to feed an ever increasing diverse populace across the globe.

Animal Biotechnology Market Trend Analysis

Genetic Modification and Precision Livestock Farming

• Currently, Genetic modification and cloning technologies for various animal production as new tool for the creation of enhanced animals with specific desirable characteristics is influencing the animal biotechnology market. These characteristics tend to include higher growth rates, greater disease tolerance and better feed conversion, all valuable tools in raising production in livestock rearing. When producers release these transgenic crops into the agricultural environment, output can be raised exponentially while paying a proportional amount of attention to resource utilization. This approach also increases economic returns to farmers and as noted above, is central to the provision of animal products in relation to increasing demand from a growing world population for food and nutrition.
• Further, application of the biotechnology in breeding has led to new method known as precision Livestock farming which is a method that combines data analysis, genomics and breeding as well as management practices for herds. Due to precision livestock farming then farmers are able to embrace high level of precision when grouping their animals for breeding these animals in a bid to embrace a higher level of precision in their breeding procedures. Through the use of technology in gene analysis and data capturing, there is an opportunity for producers to evaluate genetic traits that they consider worthy to be passed through reproduction hence a healthy and productive heard. Apart from resource management this approach also ensures sustainable farming and as we all know the society becomes conscious on the products they consume especially those obtained from animals.

Enhancing Animal Health and Welfare Through Biotechnology

• Thus, over the past few years, there has been a dramatic change in focus to improving animal health and well-being within the animal biotechnology industry. Consequently, there has been this trend of introducing and incorporating biotechnological practices in the domain of one health with special emphasis in veterinary medicine from sophisticated vaccines, diagnostic tools, and therapies. These biotechnological innovations are widely used to control some of the adverse effects of more infectious diseases on stock. Today, there is evidence of increased incidence of zoonotic diseases thereby increasing the need for efficient disease management hence driving the market for veterinary biopharmaceuticals. With this focus on health and wellness as a way of enhancing the espoused animal welfare goals, there is also the ultimate aim of strengthening animals and the subsequent livestock industries contra infectious diseases.
• In addition, regulatory authorities worldwide support the use of biotechnology application in the animal sector, hence good conditions for innovation and investment. Because these organisations understand the potential of the bio technological development they are likely to come up with policies that are much friendly as far as research and development is concerned. Similarly, the increased concern of the consumers in identifying the organic and ethical methods of production of animal farming is posing a great impact on the space of the animal biotechnology market. Special attention has been paid towards environmental friendly production processes that have improved animal health welfare. Consequently, the animal biotechnology market has enough potential for further growth and will likely find new drivers in the experiments aimed at enhancing animal productivity and increasing consumer awareness of sustainable farming.

Animal Biotechnology Market Segment Analysis:

Animal Biotechnology Market Segmented based on By Product Type, By Application, By Animal Type and By End-use

By Product Type, Diagnostics Tests segment is expected to dominate the market during the forecast period

• Diagnostics tests segment is essential in the identification and control of diseases affecting animals. This category consists of antibody testing and nucleic acid testing, polymerase chain reaction (PCR) or antigen detection test kits. These tools also help the veterinarian to diagnose diseases and other ailments at their primitive stage hence treat them. An increase in the number of zoonotic diseases across the globe and emergence of humane animal treatment more demand diagnostics in the industry. Also, increased growth in diagnostic technologies is enabling enhancement of precise diagnostic procedures, making this segment crucial to veterinary health care.
• Major advancements made in the realm of the point-of-care testing is closely related to higher rate of growth within the diagnostics tests segment. Such technologies ensure that results are produced within short durations and decisions on the treatment of animals are made on the same. With many veterinary practices moving in the direction of carrying out biometric tests at the point of care, there is a growing consideration of a one-stop-shop model of delivering care. This trend not only helps to a higher degree of diagnostics but also contributes to improved relationships between the owners of the pets and the veterinarians concerning the possible treatment of the related diseases and their prevention. In the sum, the diagnostics tests segment is expected to sustain its growth as now the advancements in technology and increased focus on travelling at the primary level of veterinary care industry revolutionizes the animal health.

By  End-use, Veterinary Hospitals & Clinics segment held the largest share in 2023

• Veterinary hospitals and clinics are the primary centers for animal health that meet the fundamental needs of pets as well as production animals. These institutions provide basic and advanced services such as annual physical examination, treatment of injuries and diseases, operations, and unique care for the animals respectively meaning that all their needs can be met in one place. Owing to growth in animal adoption rates, more and more people are now taking their pets for professional veterinarians thus increase in traffic and coming with high demand of enhanced medical services. This has been observed most profoundly with the increasing population of pet owners within the urban areas where the issue of pet health and hygiene is well understood.
• Apart from providing health care to current diseases and medical complications in animals, the veterinarian deals with the promotion of health and implementation of health-related programs in practice. Pedigree consumers are demanding health check-ups and immunization programs, as well as nutritional advice to keep their pets healthy and disease free. This change toward preventive over curative healthcare not only improves the standard of living for these animals, they also benefit the business that are the veterinary hospitals and clinics. While the variety of demands has increased, which could lead to change in a particular veterinary practice, the latter has expanded services and began investing in additional diagnostic equipment and superior treatment methods for animals, which indicates growth in the market with high quality veterinary treatment.

Animal Biotechnology Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• In North America, and especially in the United States and Canada, there is a well-developed infrastructure for biotechnological research and development for the animal biotechnology market. Many important players are located in the region, both mature companies and young businesses and startups that keep making the environment competitive. The government encourages the benefits of biotechnology by providing supportive legislation that frowns at the unsafe and unethical applications for genetically engine ered animals especially in agricultural industries. These developments are targeted to increase rate of production in livestock, raise disease tolerance, and increase feed conversion ratio thus leading to economic growth and efficiency in animal husbandry.
• Furthermore, an increase in the usage of animal biotechnology in veterinary science is also boosting the market for the region drastically. Accomplishments in vaccine and diagnostics are helpful in enhancing animal health and thereby meet the disease break outs that leads to non available food and unhealthy consumptions. With veterinarians and farmers gradually realizing value of investing in biotechnological products the market demands new products to boost health of cattle and pets. These changes also have the effect of strengthening the market foranimal biotechnology and are also cofriendly in trends towardsimproved food security and agricultural productivity, further cementing North America’s position in the sphere of global animal biotechnologies.

Active Key Players in the Animal Biotechnology Market

• Zoetis
• Boehringer Ingelheim International GmbH
• Biogénesis Bagó
• Merck & Co., Inc.
• Virbac
• Elanco
• Idexx Laboratories
• Heska Corporation
• Indian Immunologicals Ltd.
• HESTER BIOSCIENCES LIMITED
• Kareo, Inc.
• NXGN Management, LLC and Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Animal Biotechnology Market by Product Type
 4.1 Animal Biotechnology Market Snapshot and Growth Engine
 4.2 Animal Biotechnology Market Overview
 4.3 Diagnostics Tests
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Diagnostics Tests: Geographic Segmentation Analysis
 4.4 Vaccines
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Vaccines: Geographic Segmentation Analysis
 4.5 Drugs
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Drugs: Geographic Segmentation Analysis
 4.6 Reproductive & Genetic
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Reproductive & Genetic: Geographic Segmentation Analysis
 4.7 Feed Additives
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Feed Additives: Geographic Segmentation Analysis

Chapter 5: Animal Biotechnology Market by Application
 5.1 Animal Biotechnology Market Snapshot and Growth Engine
 5.2 Animal Biotechnology Market Overview
 5.3 Diagnosis of Animal Diseases
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Diagnosis of Animal Diseases: Geographic Segmentation Analysis
 5.4 Treatment of Animal Diseases
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Treatment of Animal Diseases: Geographic Segmentation Analysis
 5.5 Preventive Care of Animals
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Preventive Care of Animals: Geographic Segmentation Analysis
 5.6 Drug Development and Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Drug Development and Others: Geographic Segmentation Analysis

Chapter 6: Animal Biotechnology Market by Animal Type
 6.1 Animal Biotechnology Market Snapshot and Growth Engine
 6.2 Animal Biotechnology Market Overview
 6.3 Companion
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Companion: Geographic Segmentation Analysis
 6.4 Livestock
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Livestock: Geographic Segmentation Analysis

Chapter 7: Animal Biotechnology Market by End-use
 7.1 Animal Biotechnology Market Snapshot and Growth Engine
 7.2 Animal Biotechnology Market Overview
 7.3 Laboratories
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Laboratories: Geographic Segmentation Analysis
 7.4 Point-of-Care Testing/In-house Testing
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Point-of-Care Testing/In-house Testing: Geographic Segmentation Analysis
 7.5 Veterinary Hospitals & Clinics and Others
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Veterinary Hospitals & Clinics and Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Animal Biotechnology Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 ZOETIS
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
 8.4 BIOGÉNESIS BAGÓ
 8.5 MERCK & CO INC
 8.6 VIRBAC
 8.7 ELANCO
 8.8 IDEXX LABORATORIES
 8.9 HESKA CORPORATION
 8.10 INDIAN IMMUNOLOGICALS LTD.
 8.11 HESTER BIOSCIENCES LIMITED
 8.12 KAREO
 8.13 INC.
 8.14 NXGN MANAGEMENT
 8.15 LLC AND OTHER ACTIVE PLAYERS

Chapter 9: Global Animal Biotechnology Market By Region
 9.1 Overview
 9.2. North America Animal Biotechnology Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 Diagnostics Tests
  9.2.4.2 Vaccines
  9.2.4.3 Drugs
  9.2.4.4 Reproductive & Genetic
  9.2.4.5 Feed Additives
  9.2.5 Historic and Forecasted Market Size By Application
  9.2.5.1 Diagnosis of Animal Diseases
  9.2.5.2 Treatment of Animal Diseases
  9.2.5.3 Preventive Care of Animals
  9.2.5.4 Drug Development and Others
  9.2.6 Historic and Forecasted Market Size By Animal Type
  9.2.6.1 Companion
  9.2.6.2 Livestock
  9.2.7 Historic and Forecasted Market Size By End-use
  9.2.7.1 Laboratories
  9.2.7.2 Point-of-Care Testing/In-house Testing
  9.2.7.3 Veterinary Hospitals & Clinics and Others
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Animal Biotechnology Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 Diagnostics Tests
  9.3.4.2 Vaccines
  9.3.4.3 Drugs
  9.3.4.4 Reproductive & Genetic
  9.3.4.5 Feed Additives
  9.3.5 Historic and Forecasted Market Size By Application
  9.3.5.1 Diagnosis of Animal Diseases
  9.3.5.2 Treatment of Animal Diseases
  9.3.5.3 Preventive Care of Animals
  9.3.5.4 Drug Development and Others
  9.3.6 Historic and Forecasted Market Size By Animal Type
  9.3.6.1 Companion
  9.3.6.2 Livestock
  9.3.7 Historic and Forecasted Market Size By End-use
  9.3.7.1 Laboratories
  9.3.7.2 Point-of-Care Testing/In-house Testing
  9.3.7.3 Veterinary Hospitals & Clinics and Others
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Bulgaria
  9.3.8.2 The Czech Republic
  9.3.8.3 Hungary
  9.3.8.4 Poland
  9.3.8.5 Romania
  9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Animal Biotechnology Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 Diagnostics Tests
  9.4.4.2 Vaccines
  9.4.4.3 Drugs
  9.4.4.4 Reproductive & Genetic
  9.4.4.5 Feed Additives
  9.4.5 Historic and Forecasted Market Size By Application
  9.4.5.1 Diagnosis of Animal Diseases
  9.4.5.2 Treatment of Animal Diseases
  9.4.5.3 Preventive Care of Animals
  9.4.5.4 Drug Development and Others
  9.4.6 Historic and Forecasted Market Size By Animal Type
  9.4.6.1 Companion
  9.4.6.2 Livestock
  9.4.7 Historic and Forecasted Market Size By End-use
  9.4.7.1 Laboratories
  9.4.7.2 Point-of-Care Testing/In-house Testing
  9.4.7.3 Veterinary Hospitals & Clinics and Others
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 Netherlands
  9.4.8.5 Italy
  9.4.8.6 Russia
  9.4.8.7 Spain
  9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Animal Biotechnology Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 Diagnostics Tests
  9.5.4.2 Vaccines
  9.5.4.3 Drugs
  9.5.4.4 Reproductive & Genetic
  9.5.4.5 Feed Additives
  9.5.5 Historic and Forecasted Market Size By Application
  9.5.5.1 Diagnosis of Animal Diseases
  9.5.5.2 Treatment of Animal Diseases
  9.5.5.3 Preventive Care of Animals
  9.5.5.4 Drug Development and Others
  9.5.6 Historic and Forecasted Market Size By Animal Type
  9.5.6.1 Companion
  9.5.6.2 Livestock
  9.5.7 Historic and Forecasted Market Size By End-use
  9.5.7.1 Laboratories
  9.5.7.2 Point-of-Care Testing/In-house Testing
  9.5.7.3 Veterinary Hospitals & Clinics and Others
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Animal Biotechnology Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 Diagnostics Tests
  9.6.4.2 Vaccines
  9.6.4.3 Drugs
  9.6.4.4 Reproductive & Genetic
  9.6.4.5 Feed Additives
  9.6.5 Historic and Forecasted Market Size By Application
  9.6.5.1 Diagnosis of Animal Diseases
  9.6.5.2 Treatment of Animal Diseases
  9.6.5.3 Preventive Care of Animals
  9.6.5.4 Drug Development and Others
  9.6.6 Historic and Forecasted Market Size By Animal Type
  9.6.6.1 Companion
  9.6.6.2 Livestock
  9.6.7 Historic and Forecasted Market Size By End-use
  9.6.7.1 Laboratories
  9.6.7.2 Point-of-Care Testing/In-house Testing
  9.6.7.3 Veterinary Hospitals & Clinics and Others
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkey
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Animal Biotechnology Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 Diagnostics Tests
  9.7.4.2 Vaccines
  9.7.4.3 Drugs
  9.7.4.4 Reproductive & Genetic
  9.7.4.5 Feed Additives
  9.7.5 Historic and Forecasted Market Size By Application
  9.7.5.1 Diagnosis of Animal Diseases
  9.7.5.2 Treatment of Animal Diseases
  9.7.5.3 Preventive Care of Animals
  9.7.5.4 Drug Development and Others
  9.7.6 Historic and Forecasted Market Size By Animal Type
  9.7.6.1 Companion
  9.7.6.2 Livestock
  9.7.7 Historic and Forecasted Market Size By End-use
  9.7.7.1 Laboratories
  9.7.7.2 Point-of-Care Testing/In-house Testing
  9.7.7.3 Veterinary Hospitals & Clinics and Others
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research